RSPH ETF Analysis: SP500 Equal Weight Health | NYSE
Health | NYSE, USA | Market Cap: 739m USD | 12M Return: 18.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.57M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a passively managed fund that seeks to track an underlying index by investing at least 90% of its total assets in the indexs component securities. The index itself is built from all companies within the S&P 500 Index that are classified under the health care sector according to the Global Industry Classification Standard (GICS), a sector taxonomy jointly maintained by S&P Dow Jones Indices and MSCI.
Unlike market capitalization-weighted approaches, the funds equal weight methodology assigns each constituent a roughly identical portfolio weight at each rebalance, giving smaller health care companies the same influence on performance as the largest sector names. The GICS health care sector broadly spans four industry groups: pharmaceuticals, biotechnology & life sciences, health care equipment & services, and health care providers, though the funds holdings are restricted to those firms also included in the S&P 500.
- Drug pricing reforms pressure pharma margins across equal-weight holdings
- FDA approval pipeline drives biotech valuations in portfolio
- Interest rate cuts lift small-cap biotech weighting impact
As of July 28, 2026, the stock is trading at USD 34.13 with a total of 97,660 shares traded. Over the past week, the price has changed by +1.43%, over one month by +2.00%, over three months by +11.87% and over the past year by +18.75%.
Current recommended Stop Loss: 32.80 (which is 3.9% or 2.6 ATR below the current price).
SP500 Equal Weight Health has no consensus analysts rating.